Sponsor: Day One Biopharmaceuticals, Inc.

Collaborator: SIOPe Brain Tumor Group LOGGIC Consortium (LOGGIC)

Status: Now enrolling patients

Condition: Low-grade glioma harboring RAF alterations

Phase: 3

NCT Number: NCT05566795

EudraCT Number: 2022-001363-27

Other Study ID Numbers: LOGGIC/FIREFLY-2

Discover more details and enrollment information about FIREFLY-2
Interested in learning more?
Click here to contact a member of the Day One Clinical team